© Copyright 2025 American Medical Association. All rights reserved.
The procedure described by CPT® Code 0186T involves the suprachoroidal delivery of a pharmacologic agent, which is a method used to administer medication directly into the suprachoroidal space of the eye. The choroid, a vascular layer located between the retina and the sclera, plays a crucial role in nourishing the posterior part of the eye. The suprachoroidal space, which is the area between the choroid and the sclera, serves as a pathway for drug delivery from the anterior to the posterior segments of the eye. This technique is particularly relevant in the treatment of choroidal neovascularization, a condition often associated with age-related macular degeneration, where abnormal blood vessel growth occurs beneath the retina, leading to potential vision loss. The procedure utilizes a flexible microcannula equipped with an optical fiber, which aids in the precise placement of the catheter within the suprachoroidal space. It is important to note that while this code captures the act of drug delivery, it does not encompass the cost of the medication itself, which must be billed separately.
© Copyright 2025 Coding Ahead. All rights reserved.
The suprachoroidal delivery of a pharmacologic agent is indicated for the treatment of specific ocular conditions, particularly those involving the choroid. The primary indication for this procedure is:
The procedure for suprachoroidal delivery of a pharmacologic agent involves several critical steps to ensure accurate and effective drug administration. The steps are as follows:
Post-procedure care following the suprachoroidal delivery of a pharmacologic agent typically involves monitoring the patient for any immediate adverse reactions or complications. Patients may be advised to avoid strenuous activities and to follow up with their healthcare provider for assessment of the treatment's effectiveness and any potential side effects. Specific recovery protocols may vary based on the individual patient's condition and the medication used, but close observation is essential to ensure optimal outcomes.
| Short Descr | SUPRACHOROIDAL DRUG DELIVERY | Medium Descr | SUPRACHOROIDAL PHARMACOLOGIC AGENT DELIVERY | Long Descr | Suprachoroidal delivery of pharmacologic agent (does not include supply of medication) | Status Code | Carriers Price the Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Multiple Reduction Applies | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 20 - Other intraocular therapeutic procedures |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2014-01-01 | Deleted | Code Deleted, see 67299 |
| 2009-01-01 | Added | Code added. |
| 2008-01-01 | Added | - |
Get instant expert-level medical coding assistance.